Abstract
The aim of this Phase II, non-randomized study was to assess activity and safety of neoadjuvant chemotherapy (NACT) before chemoradiation (CT/RT) followed by radical surgery (RS) in locally advanced cervical cancer (LACC) patients. The primary end point was rate of pathologic complete response (pCR). FIGO Stage IB2-IVA patients were administered NACT chemotherapy (paclitaxel 80 mg/m2, carboplatin AUC 2), for 6 weeks, followed by Intensity Modulated Radiotherapy plus simultaneous boost (total dose of 50.4 Gy to CTV1, and 39.6 Gy to CTV2). Clinical response was assessed according to RECIST criteria. Responsive patients were triaged to RS. The regimen would be considered active if >20 pCRs were registered in 39 patients. 45 patients were enrolled into the study; 25 patients (55.5%) were FIGO stage IIB, 9 cases (20.0%) had stage III disease. At work up, pelvic lymph node involvement was documented in 38 (84.4%) patients; pCR was documented in 18 out of 40 patients (45.0%). Grade 3-4 hematological toxicity after NACT occurred in 4 patients; CT/RT associated grade 3 toxicity was found in 7 patients. Early and late postoperative complications were detected in 16, and 11 cases, respectively. Three-year PFS and OS were 66.0% and 86.0%, ...Continue Reading
Citations
Feb 15, 2019·Medicine·Peng-Hui DouYing-Jie Wu
Feb 19, 2020·Tumori·Luca BoldriniMaria Antonietta Gambacorta
Jul 17, 2019·International Journal of Clinical Oncology·Lei LiSen Zhong
Mar 3, 2020·Frontiers in Oncology·Xin TianChunlin Chen
Dec 7, 2018·Cancer Chemotherapy and Pharmacology·Gabriella FerrandinaGiovanni Scambia
Nov 19, 2019·BioMed Research International·Jie LiWenjian Xu
May 18, 2019·Medicine·Yunzhong ZhangRongfang Zheng
Mar 20, 2020·Oxidative Medicine and Cellular Longevity·Cui Hua LiuYan Nan Shen
Nov 6, 2020·Abdominal Radiology·Jia WangJie Li
Jan 21, 2021·Risk Management and Healthcare Policy·Zhen YuanHuimei Zhou
Dec 29, 2020·Frontiers in Oncology·Yanan ZhangHaibo Wang
May 1, 2021·Cancers·Simona DurantiDomenica Lorusso
Apr 13, 2020·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Alex FedericoGiuseppe Vizzielli
May 6, 2021·Current Oncology·Satomi HattoriHiroaki Kajiyama
Oct 1, 2020·ACS Applied Materials & Interfaces·Yali JunQi-Long Wang